How do clinicians assess readiness to stop or pause ADHD medication?

Clinicians approach stopping or pausing ADHD medication cautiously and collaboratively, not as a pass or fail decision. The first factor is stability. Is functioning relatively consistent across work, home, and relationships without relying on crisis level effort? If symptoms are manageable and coping strategies are actually being used rather than forced, a pause may be reasonable. They also look at why the pause is being considered. Side effects, life changes, pregnancy planning, cost, curiosity about baseline, or feeling emotionally flattened are all valid reasons. Stopping to prove something or out of guilt is usually a signal to slow the conversation down. Support matters. Clinicians assess whether external structure, routines, accommodations, or therapy are in place. Medication is easier to pause when other scaffolding exists. Without supports, stopping often leads to burnout rather than clarity. Timing is important. High demand periods are rarely ideal. Lower stress windows allow clearer assessment of what medication is doing. Finally, pauses are framed as experiments, not endings. Many clinicians recommend a planned, monitored break with check in points. Restarting is not failure. Readiness means having stability, support, and permission to adjust based on real experience rather than expectation.